Pages that link to "Q50430329"
Jump to navigation
Jump to search
The following pages link to tubulin modulators (Q50430329):
Displaying 50 items.
- vinblastine (Q282629) (← links)
- (S)-(−)-colchicine (Q326224) (← links)
- epothilones (Q408201) (← links)
- vincristine (Q408977) (← links)
- oryzalin (Q410996) (← links)
- albendazol (Q411629) (← links)
- vindesine (Q416660) (← links)
- trifluralin (Q418247) (← links)
- benomyl (Q420172) (← links)
- podofilox (Q421193) (← links)
- mebendazole (Q422194) (← links)
- paclitaxel (Q423762) (← links)
- nocodazole (Q2506092) (← links)
- discodermolide (Q2920456) (← links)
- Vinca alkaloids (Q3559405) (← links)
- ado-trastuzumab emtansine (Q3997863) (← links)
- 2-methoxyestradiol (Q4596897) (← links)
- Halichondrin B (Q4993812) (← links)
- (R)-(-)-combretastatin (Q5150954) (← links)
- maytansine (Q6720157) (← links)
- Rhizoxin (Q10861060) (← links)
- demecolcine (Q16959658) (← links)
- PFAPA syndrome: a review on treatment and outcome (Q26746971) (← links)
- Hitting the brakes: targeting microtubule motors in cancer (Q26800271) (← links)
- Beyond taxanes: the next generation of microtubule-targeting agents (Q26865369) (← links)
- patupilone (Q27093987) (← links)
- epothilone a (Q27104197) (← links)
- dolastatin 10 (Q27104943) (← links)
- docetaxel trihydrate (Q27126905) (← links)
- hemiasterlin (Q27265411) (← links)
- pbox-6 (Q27280810) (← links)
- cryptophycin 1 (Q27293933) (← links)
- Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis (Q28550301) (← links)
- Ethacrynic acid inhibition of microtubule assembly in vitro (Q30311351) (← links)
- Natural Products as Leads for Anticancer Drug Discovery: Discovery of New Chemotypes of Microtubule Stabilizers through Reengineering of the Epothilone Scaffold (Q33764743) (← links)
- Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer (Q34204598) (← links)
- Topoisomerases and Tubulin Inhibitors: A Promising Combination for Cancer Treatment (Q35552024) (← links)
- Tubulin and microtubules as targets for anticancer drugs (Q35573695) (← links)
- Antimitotic and antitubulin activity of the tumor inhibitor steganacin (Q36565188) (← links)
- Smooth muscle sensitization induced by colchicine: is it an in vitro property of antitubulin agents? (Q41871602) (← links)
- 33K Protein—An Inhibitory Factor of Tubulin Polymerization in Porcine Brain1 (Q48619670) (← links)
- Synthesis of Analogs of 2-Methoxyestradiol with Enhanced Inhibitory Effects on Tubulin Polymerization and Cancer Cell Growth (Q48657307) (← links)
- A New Culture Model Facilitating Rapid Quantitative Testing of Mitotic Spindle Inhibition in Mammalian Cells2 (Q67440183) (← links)
- Inhibition of Tubulin Polymerization by 5,6-Dihydroindolo[2,1-a]isoquinoline Derivatives (Q73846944) (← links)
- An unexplained inflammatory syndrome could be due to renal amyloidosis associated to Crohn's disease (Q83337455) (← links)
- Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer (Q113885243) (← links)
- Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma (Q113886698) (← links)
- Inductive Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients (Q113887134) (← links)
- Pancreatic Adenocarcinoma Neoadjuvant Combination Chemotherapy and Stereotactic Body Radiation Therapy Before Surgery (Q113887231) (← links)
- T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial (Q113887477) (← links)